ReviewNeuropathology of Cockayne syndrome: Evidence for impaired development, premature aging, and neurodegeneration
Introduction
Cockayne syndrome (CS) and related disorders constitute a complex of rare diseases characterized by deficient nucleotide excision-repair (NER). The pathophysiology of deficient NER for cell replication is now quite well understood, whereas the detail of the consequences of deficient NER for transcription, which plays the dominant role in CS, is less complete. One of the reasons is that there is a dearth of well-studied human cases, compared to a now rich literature on the molecular biology of NER disorders and its biochemical consequences in animal models and tissue culture.
Over the past 30 years, we and our colleagues have had the opportunity to study four cases of CS in clinical and pathological detail. We review the neuropathology of these cases and compare them to all those we were able to locate in the literature in order to illuminate major gaps in available information that future studies will need to fill. We point out pathologic features that support currently accepted pathophysiologic mechanisms and others that remain unexplained.
Cockayne syndrome (CS) is a progressive, autosomal recessive disorder that is usually present in infancy or early childhood. Most Cockayne neonates appear well formed but lag progressively behind age-peers because of severe postnatal growth failure and loss of fat. Affected children have sunken eyes, small poorly reactive pupils, sharp noses, carious teeth, and they sunburn easily. Increasing ataxia, spasticity, and a demyelinating neuropathy interfere with or preclude ambulation. Their motor, language, and cognitive development is quite delayed. Most are minimally verbal or nonverbal, but they typically have engaging personalities and few of them have seizures. Their hearing and eyesight eventually deteriorate due to cochlear pathology, corneal opacities, cataracts, retinitis pigmentosa, and optic atrophy. The disorder is slowly progressive. Dementia supervenes and most children die in late childhood, profoundly cachectic, of an intercurrent illness or, occasionally, hypertensive vascular disease. The nervous system, retina, inner ear, vascular, bony, and adipose tissues are disproportionately affected, whereas the function and structure of other organ systems are generally unimpaired despite their miniature sizes. The CS phenotype bespeaks a complex process of defective development, premature aging, and selective cell-type degeneration (Mizuguchi and Itoh, 2005).
In their comprehensive review of the clinical features of CS, Nance and Berry (1992) divided 140 published cases into three types: Type I, the most prevalent classical childhood disorder; Type II, an infrequent, very severe congenital or infantile variant that a recent review (Pasquier et al., 2006) suggests may not be quite as rare as originally suggested; and Type III, atypical later onset cases with prolonged survival.
The molecular basis of CS, which does not map systematically onto the clinical phenotypes, includes recessive mutations in either the CSA (CKN1 or ERCC8) gene (OMIM 216400) which accounts for some 20% of cases, or the CSB (CKN2 or ERCC6) gene (OMIM 133540) responsible for most of the remainder. The severity of the phenotype varies, including a UV sensitive freckled Japanese man who made no CSB protein but did not have the CS phenotype (Horibata et al., 2004). A minority of cases arises from mutations in one of the three xeroderma pigmentosum (XP) genes [XPB (ERCC6, OMIM 610651), XPD (ERCC3, OMIM 278730), or XPG (ERCC5, OMIM 278780)] in individuals who have clinical features of both disorders (Rapin et al., 2000). In some individuals XPB/CS is a relatively less severe disorder with a CS Type III phenotype, as at least three individuals survived to mid-adult life, but others have severe disease, depending in part on the location of the mutation and amount of protein produced (Oh et al., 2006). XPD/CS and, especially, XPG/CS are very severe lethal diseases of young children, some of whom have CS Type II clinical features (Lindenbaum et al., 2001). Rarely, mutation of CSB results in the cerebro-oculo-facial syndrome (COFS) (OMIM 214150), which shares many features with Type II CS or may be severe CS II. COFS may also arise from mutation of the XPD (Graham et al., 2001) or the ERCC1-XPF genes (Jaspers et al., 2007), and perhaps others. Like those with CS Type II, COFS infants have intrauterine or very early growth failure, with microcephaly, enophthalmos, cataracts, and other eye anomalies; they are severely dwarfed and mentally retarded, and die in early childhood. COFS infants differ from CS II in that they may not all develop cachexia and they have somewhat different dysmorphic facial features (Laugel et al., 2008). The arthrogryposis with which they are born denotes intrauterine lack of movement, which testifies to the severity and precocity of their neurologic involvement.
CS also overlaps with trichothiodystrophy (TTD—OMIM 601675). The TTD phenotype can be due to mutations of XPB, XPD, and two other genes TTDA and TTDN1 (Faghri et al., 2008). TTD, which is characterized in virtually all cases by sulfur deficient brittle hair and in some cases by ichthyosis, shares with CS growth failure, dysmorphism, photosensitivity, cataracts, cognitive impairment with an outgoing personality, and lack of susceptibility to cancer. Infants with TTD are more likely than those with CS to be born prematurely and to have experienced intrauterine growth retardation. Although children with TTD with cachexia have a 20-fold risk of dying before age 10 years of overwhelming infection, most are not cachectic. They do not have the progressive neurologic degeneration and premature aging of CS, but they do have mild white matter changes on imaging. If TTD is associated with intracranial calcification, MRI shows neither the dense calcifications of CS nor its dramatic atrophy of the white matter. As no autopsy report of TTD seems available, how much its neuropathology overlaps that of CS is unknown.
Overlapping clinical phenotypes in CS variants and related disorders preclude a fully satisfactory classification of cases reported without genetic characterization, especially as the same mutation of a gene does not lead reliably to a uniform phenotype (Oh et al., 2006). Among the factors that contribute to genotype–phenotype unpredictability (Boyle et al., 2008) is heterozygous mutations in different parts of the same gene, with differing consequences for transcription of messenger RNAs and amounts of protein synthesized (Nishiwaki et al., 2008). Double heterozygosity also affects differentially the non-coding RNAs that control the timing of gene expression.
Mutations in the CS and XP genes interfere differentially with the nucleotide excision-repair (NER) pathway because they code for many of the 28 proteins involved (Nouspikel, 2008). In addition, many of these proteins play additional complex metabolic roles. CSA and CSB proteins signal the need for NER of damaged DNA strand (or strands) so that accurate transcription can resume (Kraemer et al., 2007). CSB protein (less is known about CSA protein) also plays a critical role in the resumption of transcription following oxidative damage to nuclear and mitochondrial DNA, as well as in chromatin remodeling (Stevnsner et al., 2008). Signs of inadequate NER include excessive sensitivity to sun exposure, carcinogenesis, and the accumulation of repair proteins at sites of unrepaired DNA damage (Boyle et al., 2008).
Global genomic repair (GGR) hones in on single or double stranded bulky DNA-distorting lesions anywhere in the genome. It is much slower than transcription-coupled repair (TCR) of single strand errors in actively transcribing genes. Individuals with most XP mutations in whom GGR is compromised develop severe sunburn on minimal exposure, freckles, dyskeratoses, and skin cancers due to the accumulation of unrepaired mutations or gene rearrangements. In contrast, TCR is affected selectively in CS patients in whom GGR is competent and protects them from the skin and other malignancies of XP. A diagnostic hallmark of CS is extremely delayed recovery of RNA synthesis in cultured cells after irradiation with UV light, a finding used as a screening diagnostic test and for prenatal diagnosis of CS (Kleijer et al., 2006, Lehmann et al., 1993).
The four personal cases we review and compare to the available reports from the literature we were able to access include two typical Type I childhood cases, viz., Cases 2 (Soffer et al., 1979) and 3 (Gandolfi et al., 1984) studied some three decades ago; Case 4 was an adult survivor (Type III CS) (Rapin et al., 2006) and Case 1 a severely affected infant with XPG/CS (Lindenbaum et al., 2001, Moriwaki et al., 1996, Rapin et al., 2000). Our review convinced us that, besides differences in severity, there is no fundamental difference in pathology that precludes their being considered as a group.
Section snippets
Materials and methods
The pathologic and clinical material was compiled from records of the Division of Neuropathology of Albert Einstein College of Medicine and Montefiore Medical Center and from clinical records obtained by one of us (IR). Parents of three children had provided photographs for publication in scientific journals, and all four gave informed consents for detailed clinical descriptions and post mortem pathological and research studies. This review is also based upon information retrieved from a PubMed
Results
Clinical data on the four cases are summarized in Table 1. All four presented postnatally. Molecular genetic data were available in Cases 1 (XPG/CS) and 4 (CSA). Cases 2 and 3 were clinically typical Type I progressive childhood CS with subtle clinical presentation in early childhood and death in adolescence (Nance and Berry, 1992). They died more than 30 years ago outside our institution and no tissue was available for culture or DNA subtyping. Few individuals survive to adulthood (Rapin et
Discussion
The lack of either CSA or CSB protein results in failure to signal DNA damage and engage the transcription-coupled repair (TCR) cascade to excise the DNA strands blocked with lesions that obstruct polymerases and to repair them so replication or transcription can resume (Fousteri and Mullenders, 2008). In mitotic cells the consequences of deficient nucleotide excision-repair (NER) are the stalling of cell cycle progression to division, impaired transcription, or apoptosis. In post-mitotic
Conclusion
The richness of human clinical findings and detailed neuropathologic details inform experimental molecular and other studies in animal models and tissue culture and highlight many unexplained features needing investigation. CS, the other dwarfing disorders mentioned, and the severe accelerated senescence of HGPS, as well as others not mentioned here (Brooks et al., 2008) are all involved with maintaining the integrity of DNA and the repair of errors that stall replication and transcription. The
Conflict of interest
None of the authors has any to report.
Acknowledgments
We are grateful for the parents of our four cases for agreeing to the study of their children in order that others might profit from the unique learning opportunity each of them provided. We thank Dr. Pearl Rosenbaum for reviewing and editing Table 3 and Dr. Sumil Merchant for Table 4.
References (103)
- et al.
Do all of the neurologic diseases in patients with DNA repair gene mutations result from the accumulation of DNA damage?
DNA Repair (Amst.)
(2008) - et al.
Cockayne syndrome exhibits dysregulation of p21 and other gene products that may be independent of transcription-coupled repair
Neuroscience
(2007) - et al.
Ocular manifestations in the inherited DNA repair disorders
Surv. Ophthalmol.
(2003) - et al.
Cockayne's syndrome: report of a case with hyperlipoproteinemia, hyperinsulinemia, renal disease, and normal growth hormone
J. Pediatr.
(1969) - et al.
Cerebro-oculo-facio-skeletal syndrome with a nucleotide excision-repair defect and a mutated XPD gene, with prenatal diagnosis in a triplet pregnancy
Am. J. Hum. Genet.
(2001) - et al.
Brain metabolite changes on in vivo proton magnetic resonance spectroscopy in children with congenital hypothyroidism
J. Pediatr.
(1995) - et al.
Oxidative nucleotide damage and superoxide dismutase expression in the brains of xeroderma pigmentosum group A and Cockayne syndrome
Brain Dev.
(2005) - et al.
A neuropathological study of early onset Cockayne syndrome with chromosomal anomaly 47XXX
Brain Dev.
(1992) - et al.
Brain magnetic resonance imaging in suspected extrapyramidal cerebral palsy: observations in distinguishing genetic–metabolic from acquired causes
J. Pediatr.
(1997) - et al.
XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients
Mol. Cell
(2007)
Neurodegeneration in hereditary nucleotide repair disorders
Brain Dev.
Chronological changes of auditory brainstem responses in Cockayne's syndrome
Int. J. Pediatr. Otorhinolaryngol.
First reported patient with human ERCC1 deficiency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure
Am. J. Hum. Genet.
Cerebellar neurodegeneration in human hereditary DNA repair disorders
Neurosci. Lett.
Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype–phenotype relationship
Neuroscience
Cockayne's Syndrome: case report of a successful pregnancy
BJOG
Xeroderma pigmentosum/Cockayne syndrome complex: first neuropathological study and review of eight other cases
Eur. J. Paediatr. Neurol.
Cockayne syndrome in two adult siblings
J. Am. Acad. Dermatol.
DNA repair and ultraviolet mutagenesis in cells from a new patient with xeroderma pigmentosum group G and Cockayne syndrome
J. Invest. Dermatol.
Tissue-specific accelerated aging in nucleotide excision repair deficiency
Mech. Ageing Dev.
Comparative study of nucleotide excision repair defects between XPD-mutated fibroblasts derived from trichothiodystrophy and xeroderma pigmentosum patients. 3
DNA Repair (Amst.)
Nucleotide excision repair and neurological diseases
DNA Repair (Amst.)
Developing master keys to brain pathology, cancer and aging from the structural biology of proteins controlling reactive oxygen species and DNA repair
Neuroscience
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease
Neurobiol. Aging
Neuropathological findings in the cerebro-oculo-facio-skeletal Pena-Shokeir II syndrome
Brain Dev.
Demyelinating peripheral neuropathy in Cockayne syndrome: a histopathologic and morphometric study
Brain Dev.
Xeroderma pigmentosum-Cockayne syndrome complex in two patients: absence of skin tumors despite severe deficiency of DNA excision repair
J. Am. Acad. Dermatol.
Calcium-phosphate metabolism in autosomal recessive idiopathic strio-pallido-dentate calcinosis and Cockayne's syndrome
Clin. Neurol. Neurosurg.
Aicardi-Goutieres syndrome AGS
Eur. J. Paediatr. Neurol.
The role of Cockayne Syndrome group B CSB protein in base excision repair and aging
Mech. Ageing Dev.
Actin-binding proteins coronin-1a and IBA-1 are effective microglial markers for immunohistochemistry
J. Histochem. Cytochem.
Rare case of Cockayne syndrome with xeroderma pigmentosum
Acta Derm. Venereol.
AIDS: calcification of the basal ganglia in infants and children
Neurology
Oligodendrocytes: susceptibility to injury and involvement in neurologic disease
Neurology
The association between quantitative measures of dementia and of senile change in the cerebral gray matter of elderly subjects
Br. J. Psychiatry
Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophy
Hum. Mutat.
Normal pressure hydrocephalus: recognition and relationship to neurological abnormalities in Cockayne's syndrome
Arch. Neurol.
Distinctive skeletal dysplasia in Cockayne syndrome
Pediatr. Radiol.
Dwarfism with retinal atrophy and deafness
Arch. Dis. Child.
Neurological defects in trichothiodystrophy reveal a coactivator function of TFIIH
Nat. Neurosci.
Cockayne's syndrome: case report
J. Neurol. Neurosurg. Psychiatry
Pathological markers associated with normal aging and dementia in the elderly
Ann. Neurol.
Neuropathological findings in eight children with cerebro-oculo-facio-skeletal COFS syndrome
J. Neuropathol. Exp. Neurol.
The role of CSA in the response to oxidative DNA damage in human cells
Oncogene
Ubiquitin immunoreactive structures in normal human brains, Distribution and developmental aspects
Lab. Invest.
Necropsy of original case of Lowry's syndrome
J. Med. Genet.
Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestations
J. Med. Genet.
Cerebro-oculo-facio-skeletal syndrome as a human example for accelerated cochlear nerve degeneration
Otol. Neurotol.
Transcription-coupled nucleotide excision repair in mammalian cells: molecular mechanisms and biological effects
Cell Res.
Developmental Neuropathology
Cited by (113)
Endocrinopathies in Leukodystrophy
2023, Current Problems in Pediatric and Adolescent Health CareNovel Presentation of Hemiplegic Migraine in a Patient With Cockayne Syndrome
2023, Pediatric NeurologyA role for the Cockayne syndrome B (CSB)-Elongin ubiquitin ligase complex in signal-dependent RNA polymerase II transcription
2021, Journal of Biological Chemistry